Episurvey Hepatite B - A cross-sectional, multicentre, epidemiological study of the drug management in hepatitis B ARCHIVE

Head :
Bregman Bruno, Bristol-Myers Squibb
Schmidely Nathalie, Bristol-Myers Squibb

Last update : 09/05/2017 | Version : 2 | ID : 124

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name A cross-sectional, multicentre, epidemiological study of the drug management in hepatitis B
Sign or acronym Episurvey Hepatite B
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL 833542 version 9
General Aspects
Medical area Infectious diseases
Others (details) hepatitis B
Keywords Chronic hepatitis B, epidemiology, treatment
Scientific investigator(s) (Contact)
Name of the director Bregman
Surname Bruno
Address 3, rue J. Monnier - 92500 Rueil Malmaison
Phone +33 (0)1 58 83 60 00
Email bruno.bregman@bms.com
Unit Bristol-Myers Squibb
Name of the director Schmidely
Surname Nathalie
Address 3, rue J. Monnier - 92500 Rueil Malmaison
Phone +33 (0)1 58 83 60 00
Email nathalie.schmidely@bms.com
Unit Bristol-Myers Squibb
Collaborations
Funding
Funding status Private
Details Bristol-Myers Squibb
Governance of the database
Sponsor(s) or organisation(s) responsible Bristol-Myers Squibb France (BMS)
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Random sampling in clusters
Database objective
Main objective Describe the drug management of patients having chronic hepatitis B, in France, in 2006.
Inclusion criteria M/F >=18 years, infected by the hepatitis B virus for at least 6 months, seen in outpatient clinic visit at expert centers for caring of hepatitis (Hepatitis Referenced University Hospitals, General Hospital Centres, community-based hepato-gastroenterologists) between 1 Jan. and 31 March 2006.
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered General population
Gender Male
Woman
Geography area National
Detail of the geography area Metropolitan France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2006
Date of last collection (YYYY or MM/YYYY) 2006
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1800
Data
Database activity Data collection completed
Type of data collected Clinical data
Biological data
Clinical data (detail) Direct physical measures
Biological data (detail) ALT, HBe status, viral load
Presence of a biobank No
Health parameters studied Health event/morbidity
Procedures
Data collection method Case report form
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) Publications
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05